[go: up one dir, main page]

GB202003766D0 - Oral GLP receptor agonists - Google Patents

Oral GLP receptor agonists

Info

Publication number
GB202003766D0
GB202003766D0 GBGB2003766.9A GB202003766A GB202003766D0 GB 202003766 D0 GB202003766 D0 GB 202003766D0 GB 202003766 A GB202003766 A GB 202003766A GB 202003766 D0 GB202003766 D0 GB 202003766D0
Authority
GB
United Kingdom
Prior art keywords
receptor agonists
oral glp
glp receptor
oral
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2003766.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nxera Pharma UK Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GBGB2003766.9A priority Critical patent/GB202003766D0/en
Publication of GB202003766D0 publication Critical patent/GB202003766D0/en
Priority to BR112022018534A priority patent/BR112022018534A2/en
Priority to CA3175430A priority patent/CA3175430A1/en
Priority to PCT/GB2021/050661 priority patent/WO2021186169A1/en
Priority to EP21719199.8A priority patent/EP4121094A1/en
Priority to MX2022011560A priority patent/MX2022011560A/en
Priority to CN202180021540.6A priority patent/CN115666623A/en
Priority to AU2021236951A priority patent/AU2021236951A1/en
Priority to US17/909,805 priority patent/US20240270809A1/en
Priority to JP2022556031A priority patent/JP2023517766A/en
Priority to IL296464A priority patent/IL296464A/en
Priority to KR1020227031925A priority patent/KR20220154691A/en
Ceased legal-status Critical Current

Links

GBGB2003766.9A 2020-03-16 2020-03-16 Oral GLP receptor agonists Ceased GB202003766D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2003766.9A GB202003766D0 (en) 2020-03-16 2020-03-16 Oral GLP receptor agonists
KR1020227031925A KR20220154691A (en) 2020-03-16 2021-03-16 Oral GLP receptor agonists
EP21719199.8A EP4121094A1 (en) 2020-03-16 2021-03-16 Oral glp receptor agonists
CA3175430A CA3175430A1 (en) 2020-03-16 2021-03-16 Oral glp receptor agonists
PCT/GB2021/050661 WO2021186169A1 (en) 2020-03-16 2021-03-16 Oral glp receptor agonists
BR112022018534A BR112022018534A2 (en) 2020-03-16 2021-03-16 ORAL LPG RECEPTOR AGONISTS
MX2022011560A MX2022011560A (en) 2020-03-16 2021-03-16 Oral glp receptor agonists.
CN202180021540.6A CN115666623A (en) 2020-03-16 2021-03-16 Oral GLP receptor agonists
AU2021236951A AU2021236951A1 (en) 2020-03-16 2021-03-16 Oral GLP receptor agonists
US17/909,805 US20240270809A1 (en) 2020-03-16 2021-03-16 Oral glp receptor agonists
JP2022556031A JP2023517766A (en) 2020-03-16 2021-03-16 oral GLP receptor agonist
IL296464A IL296464A (en) 2020-03-16 2021-03-16 Oral glp receptor agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2003766.9A GB202003766D0 (en) 2020-03-16 2020-03-16 Oral GLP receptor agonists

Publications (1)

Publication Number Publication Date
GB202003766D0 true GB202003766D0 (en) 2020-04-29

Family

ID=70453748

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2003766.9A Ceased GB202003766D0 (en) 2020-03-16 2020-03-16 Oral GLP receptor agonists

Country Status (1)

Country Link
GB (1) GB202003766D0 (en)

Similar Documents

Publication Publication Date Title
PL4069686T3 (en) Glp-1 receptor agonist
ZA202102263B (en) Oral formulations of kappa opioid receptor agonists
IL324507A (en) Thr-beta receptor agonist compound and preparation method and use thereof
IL304521A (en) Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
HUE071004T2 (en) Glp-1 receptor agonist and use thereof
SG11202112163XA (en) Melanocortin-4 receptor agonists
GB201911187D0 (en) Receptor
IL292601A (en) Npy2 receptor agonists
IL288536A (en) Il2 agonists
GB202003762D0 (en) GLP receptor agonists
GB201816637D0 (en) Selective somatostatin receptor agonists
GB202003766D0 (en) Oral GLP receptor agonists
GB202003764D0 (en) Oral GLP receptor agonists
GB201903953D0 (en) Oral GLP receptor agonists
GB201903951D0 (en) Oral GLP receptor agonists
HK40079212A (en) Oral glp receptor agonists
GB202011604D0 (en) GLP-1 receptor antagonists
ZA202307999B (en) Carboxy substituted glucocorticoid receptor agonists
CA211614S (en) Arm sleeve
GB201903985D0 (en) GLP receptor agonists
GB202105846D0 (en) GPR35 Agonist compounds
HK40079209A (en) Glp receptor agonists
GB201903900D0 (en) Adenosine receptor agonists
GB202110135D0 (en) Muscarinic receptor agonists
GB202309615D0 (en) Muscarinic receptor agonists

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)